BIOS Capital Management, LP Long-Term Concentrated

CIK: 0001813845 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 12, 2025

Total Value ($000): $88,913 (100.0% shares, 0.0% debt)

Holdings (6)

ACTU ACTUATE THERAPEUTICS INC 75.6%

Value ($000) $67,234 Shares 10,049,996 Est. Cost $8.16 Unrealized -11.2%

CGTX COGNITION THERAPEUTICS INC 9.1%

Value ($000) $8,100 Shares 6,000,000 Est. Cost $0.49 Unrealized +175.8%

IRD OPUS GENETICS INC 7.4%

Value ($000) $6,593 Shares 3,683,429 Est. Cost $0.99 Unrealized +26.0%

LTRN LANTERN PHARMA INC 5.0%

Value ($000) $4,418 Shares 1,015,715 Est. Cost $3.42 Unrealized +21.9%

RNTX REIN THERAPEUTICS INC 2.2%

Value ($000) $1,944 Shares 1,690,751 Est. Cost $3.03 Unrealized -58.1%

— IN8BIO INC 0.7%

Value ($000) $622 Shares 286,664 Est. Cost $0.26 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACTU	ACTUATE THERAPEUTICS INC	10,049,996	$67,234	75.6%	$8.16	-11.2%	COM	005083100
CGTX	COGNITION THERAPEUTICS INC	6,000,000	$8,100	9.1%	$0.49	+175.8%	COM	19243B102
IRD	OPUS GENETICS INC	3,683,429	$6,593	7.4%	$0.99	+26.0%	COM	67577R102
LTRN	LANTERN PHARMA INC	1,015,715	$4,418	5.0%	$3.42	+21.9%	COM	51654W101
RNTX	REIN THERAPEUTICS INC	1,690,751	$1,944	2.2%	$3.03	-58.1%	COM NEW	00887A204
—	IN8BIO INC	286,664	$622	0.7%	$0.26	—	COM	45674E109